We also need a metric of harm to the individuals who are doing the drugs. If they're doing less severe drugs with less adulterants for a cheaper price (less nee

We also need a metric of harm to the individuals who are doing the drugs. If they're doing less severe drugs with less adulterants for a cheaper price (less need to turn to theft) with medical support then it could still be a win even if % usage is up.